BackReata Pharmaceuticals Overview
Reata Pharmaceuticals Inc - Class A

Reata Pharmaceuticals Target Price

Analysts' 12-month price predictions for RETA.

Get informed when a big investor buys or sells

+ Follow

Share Price

$172.36

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-11-28Goldman Sachs$11533.3% downsideOpen
2022-08-09Robert W. Baird$2784.3% downsideOpen
2022-08-08Goldman SachsMadhu Kumar$7655.9% downsideOpen
2022-05-27Citigroup$4673.3% downsideOpen
2022-05-24Goldman Sachs$7357.6% downsideOpen